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Resuscitative interventions that improve systemic and mesenteric perfusion 
without causing instability in systemic arterial pressures may be helpful for improving 
trauma patient outcomes. Blocking angiotensin I1 formation with enalaprilat may be such 
an intervention. In this study involving resuscitation fiom hemorrhagic shock in dogs, 
the systemic and mesenteric cardiovascular effects of administering enalaprilat during 
resuscitation were investigated. Thermodilution-based and ultrasound-based methods of 
monitoring the systemic blood flow were also examined. Animals were hemorrhaged to 
a mean arterial pressure (MAP) of 40-45mmHg for 30min then 30-35mmHg for 30min 
followed by resuscitation with intermittent lactated Ringer's solution (200ml/kg/hr during 
first 4Omin, 60ml/kg/hr during following 130min) to reach and maintain a mean arterial 
pressure of 75-80mmHg for 170min. A constant rate infusion of saline vehicle with or 
without enalaprilat (0.02mgkglhr) was initiated after 40min of resuscitation. Systemic 
and mesenteric blood flows declined with hemorrhage, increased in all dogs with 
resuscitation, and then declined during the initial 40min of resuscitation. Enalaprilat 
administration resulted in increases in systemic and mesenteric blood flows not seen in 
the controls. The greater flows with enalaprilat appeared to be due to prevention of the 
increases in afterload noted in the controls. Comparison of monitoring techniques, 
showed stronger correlation between the ultrasonically determined descending thoracic 
aortic blood flow and celiac artery flow than between thermodilution determined cardiac 
output and celiac artery flow. It can be concluded that administration of a constant rate 
infusion of enalaprilat during resuscitation can be used to improve systemic and 
mesenteric blood flow and that passive methods of monitoring systemic blood flow, such 
as transesophageal ultrasound, may more accurately represent flow parameters than do 
bolus requiring methods, such as intermittent thermodilution. 
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INTRODUCTION 
Hemorrhage lea&, to reductions in systemic and, even more so, in mesenteric 
perfusion (Toung et al., 2000). Restoration of systemic cardiovascular parameters after 
trauma, however, is not always accompanied by restoration of gastrointestinal energy 
status (Ivatury et al., 1996; Van Way et al., 1996). Patients in whom gastrointestinal 
energy status is normalized more quickly have a decreased incidence of multiple organ 
dysfunction and death (Ivatury et al., 1 996; Chang et al., 1 994; Kirton et al., 1 998). 
Accordingly, early institution of resuscitative interventions that improve not only global 
systemic cardiovascular parameters, but also mesenteric blood flow may be beneficial. 
Angiotensin I1 has been shown to be responsible for the disproportionate mesenteric 
vasoconstriction that occurs in response to hemorrhage (Toung et al., 2000). 
Administration of an angiotensin converting enzyme inhibitor during resuscitation would 
be a reasonable approach for increasing mesenteric blood flow. Benefits fiom 
interference with angiotensin 11-mediated processes before, during, and after shock have 
been reported (Toung e t  al., 2000; Aneman et al., 1997; Wall et al., 1999; Kincaid et al., 
1998; Aneman et al., 2000; Wall et al., 2002). A smaller decrease in mesenteric 
perfusion in pig hemorrhagic shock models resulted when the angiotensin converting 
enzyme inhibitor enalaprilat (Merck Company Inc.) was administered before hemorrhage 
(Toung et al., 2000; Aneman et al., 1997). A greater increase in metabolic activity, 
indicated by increasing body temperature (Henderson et al., 1999), and a greater survival 
to 48 hours (Wall et al., 1999) occurred when enalaprilat was administered during 
resuscitation in a rat hemorrhagic shock and resuscitation model. In human trauma 
patients, an h ~ e a s e  in cardiac output and a decrease in gastric PiC02, indicating 
2 
improved gastric mucosal energy status, resulted when enalaprilat was administered 
during resuscitation (Kincaid et al., 1998). Despite an intentionally hypotensive 
resuscitation protocol, administration of enalaprilat to dogs during resuscitation from 
hemorrhage was also associated with an increase in cardiac index as well as increases in 
superior mesenteric artery and portal vein blood flow, all without adversely affecting 
systemic arterial pressure maintenance (Wall et al., 2002). 
In addition to angiotensin converting enzyme inhibition, angiotensin I1 sub-type 1 
receptor blockade has also shown benefits. A smaller decrease in mesenteric perfusion 
and increased survival occurred in a pig model of hemorrhagic shock and resuscitation 
when candesartan, an angiotensin I1 sub-type 1 receptor blocker was administered before 
hemorrhage ( h e m a n  et al., 2000). Angiotensin I1 sub-type 1 receptor blocker 
administration during resuscitation of  trauma patients, however, has not been reported. 
Not all drugs that prevent either formation of angiotensin I1 or interaction of angiotensin 
I1 with receptors are likely to be equally beneficial (Guba et al., 2000; Schindler et al., 
1995). 
This study investigated the systemic and mesenteric cardiovascular effects of 
administering a constant rate infusion of enalaprilat during normotensive resuscitation 
from hemorrhage with lactated Ringer's solution. This is a continuation from previous 
work which demonstrated that systemic arterial pressures could be maintained while 
administering a constant rate infusion of enalaprilat during moderately hypotensive 
resuscitation, and that administering a constant rate infusion of enalaprilat during severely 
hypotensive resuscitation improved systemic cardiovascular status and, importantly, 
mesenteric blood flow despite the severe hypotension (Wall et al., 2002). In addition, this 
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study compared two of assessing systemic blood flow: intermittent 
themodilution using a pulmonary artery catheter and ultrasound using a transesophageal 
combined M-mode and pulsed Doppler ultrasound probe. 
MATERIALS AND METHODS 
This research was conducted in accordance with the: National Institutes of Health 
guidelines for experiments involving animals, provisions of the USDA Animal Welfare 
Act, Animal and Plant Health Inspection Services (APHIS) Guide for the Care and Use of 
Laboratory Animals, and US Interagency Research Animal Committee Principles for the 
Utilization and Care of Research Animals. The protocols were approved by the Animal 
Care and Use Committee, Veterans Administration Central Iowa Health Care System, 
Des Moines, Iowa. All experiments were undertaken in the Veterans Administration 
Central Iowa Health Care  System Surgical Teaching Laboratory, an Association for 
Assessment and Accreditation of Laboratory Animal Care (AAALAC) accredited facility. 
Animal Model 
Mongrel dogs (2 1 -8 + 0.5 kg, City of Des Moines Animal Shelter) were used for all 
experiments. The night prior to surgery, food was withheld. Water was available ad 
libitum. Dogs randomized to enalaprilat or control before anesthesia and the group 
to which they were randomized was kept concealed until all ten had been completed. 
Blinding was maintained by having technicians who were not otherwise involved in the 
study randomize the dogs and prepare the appropriate enalaprilat in saline (0.07% 
physiological saline, Wall  et al., 2002, hereafter referred to as saline) solution or saline 
alone solution for administration during resuscitation. All of the dogs that survived 
hemorrhage and resuscitation were euthanized with 0.22 mllkg of ~ u t h a s o l ~  (Delmarva 
laboratories, Midlothian, Virginia, USA) administered intravenously at the end of 
resuscitation. The minimum number of subjects per treatment was determined by power 
analysis (GraphPad Prism version 3.02 for Windows, GraphPad Software, San Diego, CA 
and SAS@, SAS Institute, Inc., Cary, NC). Previous work by Wall et al., 2000 
demonstrated a 20% loss. 
Anesthesia 
Animals were prernedicated with xylazine (1 mgkg, intramuscularly, Phoenix 
Pharmaceutical Inc.) and atropine (0.8 mL intramuscularly, American Pharmaceutical 
Partners), induced with thiopental (Abbott Laboratories), and kept anesthetized with a 
constant rate infusion of thiopental. Local anesthesia in the form of 1 .O% lidocaine 
(Baxter Health Care Inc.) was also used at incision sites. 
Instrumentation 
The locations and purposes of the items placed in the dogs are found in Table 1. 
Except for the left cephalic vein, cut-downs were used to place the vascular catheters, and 
the incisions were sutured closed. Normal saline was run through the left brachial arterial 
catheter at 1 ml/kg/h. Lactated Ringer's solution was run through the other three arterial 
catheters at 0.2 mlkghr. The intra-abdominal catheters and sensors were placed via 
laparotomy. The laparotomy was closed with towel clamps after instrumentation so that 
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1 cm3 hepatic and gastric mucosal samples could be obtained at several time points in 
each dog and preserved for later analysis. 
Hemorrhage 
After obtaining baseline measurements, dogs were bled to and maintained at a mean 
arterial pressure of 40 - 45 mm Hg for 40 rnin (Figure 1). The end of the first 
hemorrhage 
samples and measurements were obtained during the last 10 min of this first interval. 
During the second hemorrhage dogs were bled to and maintained at a mean arterial 
pressure of 30 - 35 rnrn Hg for 40 min. The end of the second hemorrhage samples and 
measurements were obtained during the last 10 min of the second hemorrhage interval. 
Then resuscitation commenced. Resuscitation was begun earlier if the mean arterial 
pressure dropped below 30 mm Hg for 10 min, or below 25 mm Hg for 1 min. In the 
event that resuscitation was started early, the appropriate samples and measurements were 
obtained as rapidly as possible and were considered to represent both the end of the 
second hemorrhage and the start of resuscitation. 
Table I. Instrumentation 
Item 
2 1 gauge butterfly 
extension 
endotracheal tube 
ventilator 
mainstream end-tidal C02 
monitor 
pulse oximeter 
esophageal stethoscope 
transesophageal M-mode 
and pulsed Doppler 
ultrasound probe 
(HemosonicB, Arrow 
International, Reading, 
PA) 
ECG leads 
7.5 Fr thermodilution 
cathetera 
8 Fr 2 lumen catheter 
12 Fr 2 lumen catheters 
7 Fr 3 lumen catheter 
Foley catheter 
4 Fr 1 lumen catheters 
fiber-optic sensorsb 
transit time ultrasound 
flow probesc 
aArterial pressures and cardiac 
Monitor (S paceLabs Medical, Redmond, Washington, USA). 
b~iber-optic sensors were ~eotrends" (Diametrics Medical, St. Paul, Minnesota, USA). 
'Celiac arterial flow and portal vein flow were monitored using a ~ransonics@ T206 monitor 
(Transonics Systerns Inc., Ithaca, New York, USA). 
Location 
lefl cephalic vein 
trachea 
near head of dog 
attached to endotracheal 
tube 
tongue 
esophagus 
esophagus 
skin 
right external jugular vein to 
pulmonary - -  artery - 
right brachial artery 
1. right femoral artery 
2. left femoral artery 
right femoral vein 
bladder 
I. left brachial artery 
2. upper thoracic esophagus 
3. through gastric wall 
4. through duodenal wall 
I .  left brachial artery 
2. esophageal lumen 
3. gastric lumen 
4. duodenal lumen 
I .  around the celiac artery 
2. around the portal vein 
output were monitored using 
Purpose 
induction and constant rate infusion 
of thiopental for anesthesia 
airway control 
SiMV at tidal volume=& 12mLkg 
and rate=25-45 breaths/min for 
P,C02=35-45mmHg 
end-tidal C02 and respiratory rate 
s~o2 
cardiac auscu Etation 
lef3 ventricular ejection time interval 
and descending thoracic aortic: 
1. blood flow 
2. stroke volume 
3. diameter 
4. blood maximal acceleration 
5. blood peak velocity 
ECG and heart rate 
CVP, PAP, PAOP, CO, mixed 
venous samples for Sv02 
bleeding, systemic arterial pressures 
back-up site 
systemic arterial pressures, bleeding 
back-up sites 
resuscitation fluids 
eollecting urine 
fiber-optic sensor placements 
I .  continuous pHa, P,C02, P,02, BE, 
S D 2  
2. ePiC02 
3. gP,C02 
4. dPiC02 
1. celiac artery blood flow 
2. portal vein blood flow I 
a SpaceLabs Medical PC2 Bedside 
- - -- --- - -- - -- - - - -- - - - 1 
Start Constant Rate Infbsion 
2 rnlkgfhr  saline t: 0.0 I mg enaVmL a 
2 80 
70 
I, Y - 1 I 
200ml/kg/hr ah-nl/kg/hr 
of LRS N of LRS lV 
I 
'" 6 0 -  2 Hemorrhage intermittently mtermittentb 
a 50 - 
.I 
as needed as needed 
.- 40 - \  
L $ 30 - I Resuscitation 
Time (min) 
Figure 1. Hemorrhage and resuscitation protocol. The line represents the mean arterial 
pressure (MAP) (shown on the y-axis) over time fiom the baseline (shown on the x-axis). 
Resuscitation 
After hemorrhage, each dog was resuscitated with intermittent intravenous lactated 
Ringer's solution at 200 mLkg/hr titrated to reach and maintain mean arterial pressure at 
75 - 80 mm Hg (Figure 1). After the first 40 min interval, the rate of lactated Ringer's 
solution for intermittent administration was reduced to 60 rnl/kg/hr and a constant rate 
infusion of either saline vehicle with enalaprilat (0.02 mg enalaprilat/kg/hr, n = 5) or 
without enalaprilat (n = 5) was administered intravenously for 13 0 rnin. The saline 
vehicle infusion rate for both treatment and control animals was 2 r n L k g h .  
Resuscitation samples and measurements were taken at the start of resuscitation, after 30 
min of resuscitation, at the start of the constant rate infusion of the saline vehicle with or 
without enalaprilat, and every 30 min following the initiation of the constant rate 
infusion. 
Measurements And Samples 
Descending thoracic aortic blood flow variables, systemic arterial pressures, 
pulmonary arterial pressures, central venous pressure, heart rate, Sp02, PaOz, PaC02, pHa, 
and BEa were continuously monitored and were recorded at 1 min intervals. Arterial 
blood samples were taken for blood gas analysis and hemoglobin determination at 
baseline, the start of resuscitation, and the end of resuscitation. Mixed venous blood 
samples were taken at baseline and at the end of each hemorrhage and resuscitation 
interval. Using a pulmonary artery thermodilution catheter, cardiac output and pulmonary 
artery occlusion pressure were measured at baseline and at the end of each hemorrhage 
and resuscitation interval. Ten mL cold saline was used as the injectate bolus for 
determining cardiac output. Cardiac index (CI) and stroke volume index (SVI) were 
calculated from the cardiac output and heart rate values. The body surface area 
calculation used for indexing was as follows: body surface area (m2) = [weight (kg)Oe6' x 
10.1]/10~ (Chang et al., 2000). Stroke work index (SWI; Reilly et al., 2001), left 
ventricular power output index (LVPI; Yamazaki et al., 199 1 ; ATLS 1997 ), and arterial 
elastance index (EaI; Reilly et al., 2001) were calculated using the following equations: 
S WI = SVI x femoral mean arterial pressure; LVPI = CI x (femoral mean arterial 
pressure - central venous pressure); EaI = femoral mean arterial pressureISV1. Aortic 
blood flow index and aortic stroke volume index were calculated from the aortic blood 
flow and the heart rate values. 
Statistical Analysis 
Quantitative data are reported as means the standard errors of the mean (SEM). 
Data was analyzed using two-way repeated measures ANOVA using commercially 
available statistical software programs (GraphPad Prism version 3.02 for Windows, 
GraphPad Software, San Diego, CA and SAS@, SAS Institute, Inc., Cary, NC). A p 
value of less than 0.05 was considered statistically significant. 
RESULTS 
Hemorrhage 
Hemorrhage decreased blood pressure, cardiac index, and descending thoracic aortic, 
celiac arterial, and portal venous blood flow (Figures 2a,2b,2c, 3a,3b, and Table 2). The 
severity of the metabolic insult caused by the hemorrhage is indicated by the decreases in 
arterial base excess and S,02 (Table 2), increases in gastrointestinal PiCOz (Table 2), and 
the pre-resuscitation death of two dogs, one from each group. 
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Figure 2a. Mean arterial pressure during hemorrhage and resuscitation with and without 
enalaprilat in each dog. Hemorrhage started at time = 1 minute, resuscitation at time = 8 1 
minutes, constant infusion rate of enalaprilat or control saline vehicle at time = 12 1 minutes. 
Abbreviations: E = enalaprilat group, C = control group, numbers indicate individual animals. 
Time (min) 
Figure 2b. Volumes of lactated Ringer's solution administered during resuscitation with and 
without enalaprilat to each dog. Hemorrhage started at time = 1 minute, resuscitation at time = 
8 1 minutes, constant infusion rate of enalaprilat or control saline vehicle at time = 121 minutes. 
Abbreviations: E = enalaprilat group, C = control group, numbers indicate individual animals. 
Time (min) 
Figure 2c. Cardiac indices during hemorrhage and resuscitation in each dog. Data from animals 
that received enalaprilat are shown with solid markers, and data from control animals are shown 
with open markers. Hemorrhage started at time = 1 minute, resuscitation at time = 8 1 minutes, 
constant infusion rate of enalaprilat or control saline vehicle at time = 12 1 minutes. 
Abbreviations: E = enalaprilat group, C = control group, numbers indicate individual animals. 
Time (rnin) 
Figure 3a. Average cardiac indices and decending thoracic aortic, portal venous, and celiac 
artery blood flow indices during hemorrhage and resuscitation in the enalaprilat group. 
Hemorrhage started at time = 1 minute, resuscitation at time = 81 minutes, constant rate infusion 
of enalaprilat or control saline vehicle at time = 12 1 minutes. Enalaprilat descending thoracic 
aortic blood flow index values from 150 min to 203 min on the x-axis represent values from only 
3 dogs. Enalaprilat descending thoracic aortic blood flow index values fiom 203 min to 233 min 
on the x-axis represent values from only 2 dogs. Enalaprilat descending thoracic aortic blood 
flow index values from 233 rnin onward represent values from only 1 dog. Control cardiac index 
values beyond 19 1 min on the x-axis represent values fiom only 3 dogs. Control descending 
thoracic aortic blood flow index values from 242 min onward represent values fiom only 3 dogs. 
Abbreviation: CI = cardiac index. 
+ Aortic 
-A- Portal 
Time (min) 
Figure 3b. Average cardiac indices and decending thoracic aortic, portal venous, and celiac 
artery blood flow indices during hemorrhage and resuscitation in the control group. Hemorrhage 
started at time = 1 minute, resuscitation at time = 8 1 minutes, constant rate infusion of enalaprilat 
or control saline vehicle at time = 12 1 minutes. Enalaprilat descending thoracic aortic blood 
flow index values from 150 min to 203 min on the x-axis represent values fiom only 3 dogs. 
Enalaprilat descending thoracic aortic blood flow index values from 203 min to 233 min on the 
x-axis represent values fiom only 2 dogs. Enalaprilat descending thoracic aortic blood flow 
index values from 233 min onward represent values from only I dog. Control cardiac index 
values beyond 19 1 min on the x-axis represent values from only 3 dogs. Control descending 
thoracic aortic blood flow index values from 242 min onward represent values from only 3 dogs. 
Abbreviation: CI = cardiac index. 
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Resuscitation 
Since the administration of lactated Ringer's solution was titrated so as to maintain 
the mean arterial pressure in the resuscitation target range of 75 - 80 mm Hg, the dogs 
received varying amounts of lactated Ringer's solution throughout the course of 
resuscitation (Figure 2b). During the intitial40 minutes of resuscitation, there was not a 
significant difference in requirements for lactated Ringer's solution between groups (53 + 
1 1 rnllkg in enalaprilat group versus 38 f 10 mlkg in control group, p=0.4). Both groups 
also had increases in systemic and mesenteric blood flows with the initiation of 
resuscitation. Over time, however, systemic and mesenteric blood flows declined in the 
control dogs and ended higher in the enalaprilat dogs (Figures 3a and b). The data in 
Table 2 show that the changes in systemic blood flow were the result of changes in stroke 
volume, not heart rate. 
Following initiation of the constant rate infusion at 40 minutes into resuscitation (120 
minutes into the protocol), two of the control dogs took very little to no additional 
lactated Ringer's solution. These two control dogs generally had resuscitation mean 
arterial pressures greater the 80 mrn Hg (Figures 2a,b,c; C1, C3). The other two control 
dogs and two of the enalaprilat dogs had relatively indistinguishable mean arterial 
pressures (Figures 2a,b,c; C2, C4, E3, E4). Following initiation of the constant rate 
infusion, these two control dogs (C2, C4) required 40.3 and 5 1.2 ml/kg lactated Ringer's 
solution, and the two enalaprilat dogs (E3, E4) with similar mean arterial pressures 
required 26.4 and 68.2 mllkg lactated Ringer's solution. Over this time frame, these two 
enalaprilat dogs (E3, E4) generally had greater cardiac indices than any of the control 
dogs. 
The other two enalaprilat dogs' (El, E2) mean arterial pressures were not well 
maintained in the target range of 75 - 80 mm Hg following initiation of the constant rate 
infusion despite continuous administration of lactated Ringer's solution. Though dog El 
had mean arterial pressures below the target range throughout the constant rate infusion 
period, a fluid pump error likely contributed. Dog E l  received only 2,087 mL of lactated 
Ringer's solution but should have received up to 390 additional millilters of lactated 
Ringer's solution. These two enalaprilat dogs (El, E2), however, had the highest cardiac 
indices and stroke volume indices throughout the constant rate infusion period (Figure 2c 
and Table 2). 
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Table 2. 
LRS 
MAP mmMg 
control 
'enalaprilat 
tIR beats/min 
control 
'enalaprilat 
I'AOP mm I Ig 
control 
enalaprilat 
SVI rnL,/rn2 
control 
'enalaprilat 
ASVI r n ~ / r n ~  
control 
'enalaprilat 
BE, mEq/L 
control 
enalaprilat 
SVO2 % 
control 
'enalaprilat 
DO21 
mllm i n/m2 
control 
enalaprilat 
VOz1 
m Urn i n/m2 
control 
enalaprilat 
Hb g/dL 
control 
enalaprilat 
Urine mL/kge 
control 
enalaprilat 
ePiCOz mmHg 
control 
enalaprilat 
gPiC02 mrniig 
control 
enalaprilat 
dPiC02 rnmllg 
control 
enalaprilat 
aThe p-value 
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"The urine volumes are cumulative. 
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In terms of group averages following the initiation of the constant rate infusion, the 
enalaprilat group had a lower average mean arterial pressure (p<O.000 1 ), required more 
lactated Ringer's solution (0.002), and had a higher average cardiac index (p=0.0001), 
stroke volume index (p=0.0014), celiac arterial flow (p<O.0001), and portal venous flow 
(p=0.0002). In the enalaprilat group, the increase in celiac arterial flow following 
initiation of the constant rate infusion of enalaprilat was quite marked, and its pattern 
matched that of the ultrasonically determined descending thoracic aortic blood flow better 
in every dog than it matched that of the thermodilution determined cardiac output (Figure 
3a and Table 3). 
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Figure 4a. Average stroke work indices during hemorrhage and resuscitation. The average 
stroke work indices following the initiation of the constant rate infusion were higher in the 
enalaprilat group than in the control group (p = 0.003). Control values beyond 19 1 min on the x- 
axis represent values from only 3 dogs. Hemorrhage started at time = 1 minutes, resuscitation at 
time = 8 1 minutes, constant rate infusion of enalaprilat or control saline vehicle at time = 121 
minutes. 
Time (min) 
Figure 4b. Average left ventricular power output indices during hemorrhage and resuscitation. 
The average left ventricular power output indices following initiation of the constant rate 
infusion were higher in the enalaprilat group than the control group (p = 0.0094). Control values 
beyond 19 1 min on the x-axis represent values from only 3 dogs. Hemorrhage started at time = 1 
minutes, resuscitation at time = 81 minutes, constant rate infksion of enalaprilat or control saline 
vehicle at time = 121 minutes. 
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Figure 4c. Average arterial elastance indices during hemorrhage and resuscitation. The average 
arterial elastance indices following initiation of the constant rate infusion were lower in the 
enalaprilat group than the control group (p = 0.0001). Control values beyond 191 min on the x- 
axis represent values from only 3 dogs. Hemorrhage started at time = 1 minutes, resuscitation at 
time = 8 1 minutes, constant rate infusion of enalaprilat or control saline vehicle at time = 12 1 
minutes. 
Table 3. Comparison of Values Obtained for Cardiac Output, Descending Thoracic 
Aortic Blood Flow, and Celiac Artery Blood Flow Measured by Different Techniques 
I 
Systemic Flow-Pressure Related Parameters During Resuscitation 
Dog 
Enalapri iat I 
Enalaprilat 2 
Enalaprilat 3 
Enalaprilat 4 
Control 1 
Control 2 
Control 3 
Control 4 
Stroke work index and left ventricular power output index were higher during 
resuscitation in the enalaprilat dogs than in the control dogs (p=0.003 and p=0.0094, 
Time points for comparison were those at which cardiac output was measured by 
thermodilution. Abbreviations: CO = cardiac output measured using thermodilution, 
ABF = descending thoracic aortic blood flow measured using combined M-mode and 
pulsed Doppler ultrasound, Celiac = celiac arterial blood flow measured using transit time 
ultrasound. 
respectively; Figures 4a,b). Arterial elastance index, a measure of afterload, was lower 
Points Compared 
ABF versus Celiac 
0.9 1, 10 time points 
0.9 1, 1 1 time points 
0.94, 7 time points 
0.89, 6 time points 
0.83, 12 time points 
0.94, 10 time points 
0.84, 12 time points 
0.98, 10 time points 
Pearson Correlation Coefficients, Number of Time 
during resuscitation in the enalaprilat dogs than in the control dogs (p=0.0001 enalaprilat 
CO versus ABF 
0.78, 10 time points 
0.9 1, 1 1 time points 
0.91, 12 time points 
0.85, 6 time points 
0.65, 12 time points 
0.9 1, 10 time points 
0.19, 12 time points 
0.76, 1 1 time points 
versus control; Figure 4c). In the control dogs arterial elastance generally increased 
CO versus Celiac 
0.85, 10 time points 
0.84, 11 time points 
0.74, 7 time points 
0.8 1,6 time points 
0.32, 12 time points 
0.84, 10 time points 
0.64, 12 time points 
0.80, 10 time points 
during resuscitation. 
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Esophageal And Gastrointestinal PiC02 During Resuscitation 
Declines in PiC02 at each monitored site occurred with the initiation of resuscitation. 
The PiC02 values in both groups generally reached or were below baseline by the start of 
the respective constant rate infusions (Table 2). Due to a variety of fiber-optic 
instrumentation constraints, not all PiC02 values were available in all dogs. 
Pulmonary Artery Catheter Knot 
Thermodilution dependent values were not obtained in one of the control dogs beyond 
1 10 min of resuscitation (70 min after the initiation of the control constant rate infusion). 
When an appropriate pulmonary artery trace was lost and repositioning attempted, 
resistance was encountered and a few premature ventricular contractions occurred. The 
catheter was then left in place and not used through the remainder of resuscitation in this 
dog. An intracardiac knot in the pulmonary artery catheter was found on necropsy. 
Transesophageal Ultrasound of Descending Thorack Aortic Flow Parameters 
It was discovered that the transesophageal ultrasound probe used to obtain descending 
thoracic aortic blood flow values requires occasional repositioning if the stomach is 
manipulated. The loss of well defined aortic walls on the M-mode trace can occur 
without loss of the audible Doppler derived representation of blood flow, and no data will 
be collected in the absence of well defined aortic walls on the M-mode. With the version 
of the Hernosonic used in this study, real time data collection and storage was apparently 
suspended when the data trends screen was visible. These discoveries came at the 
expense of some descending thoracic aortic blood flow data (Figures 3 b,3c). 
DISCUSSION 
This study had four major findings. (1) Enalaprilat improved systemic blood flow. 
(2) Enalaprilat improved mesenteric blood flow. (3) The transesophageal ultrasonic 
method of monitoring systemic blood flow correlated well with the intermittent 
thermodilution method. (4) The results with the transesophageal ultrasonic method of 
monitoring systemic blood flow suggested that it may have advantages over intermittent 
thermodilution based monitoring independent of its continuous and less invasive nature. 
Greater Systemic And Mesenteric Blood Flow During Resuscitation With 
Enalaprilat 
Consistant with previous findings in a hypotensive resuscitation protocol (Wall et al., 
2002), the group that received the enalaprilat infusion had greater systemic and 
mesenteric flows at the end of resuscitation. In this hypotensive resuscitation protocol, 
the base excess at the start of the constant rate infusion was strongly correlated with the 
amount of lactated Ringer's solution required irrespective of treatment group, and no 
difficulty was encountered in maintaining target mean arterial pressures with intermittent 
administration of lactated Ringer's solution as needed at 60 mLkg/hr (Wall et al., 2002). 
In the current resuscitation protocol, with target mean arterial pressures of 75 - 80 mm Hg 
and intermittent administration of lactated Ringer's solution as needed at 60 mL/kg/hr, 
the base excess at the start of the constant rate infusion was not strongly correlated with 
the amount of lactated Ringer's solution required, and two of the dogs that received 
enalaprilat were not maintained in the target mean arterial pressure range following 
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initiation of the enalaprilat constant rate infusion. During this period, however, these two 
dogs had the highest cardiac indices and stroke volume indices of all of the dogs and had 
higher celiac arterial flows than did the controls. The cardiac indices and stroke volume 
indices of the other two enalaprilat dogs following initiation of the enalaprilat infusion 
were also generally higher than any of the controls. They also had increasing celiac 
arterial flows with the enalaprilat infusion while celiac arterial flows in the controls 
generally declined during the constant rate infusion period. 
Blood Flow Relationship With Blood Pressure 
Looking at the systemic and the mesenteric blood flow in concert with the blood 
pressure reinforces the point that blood pressure is a very poor indicator of blood flow. In 
fact, even with an average infusion period mean arterial pressure of 41 f 0 mm Hg, the 
average final cardiac index in the previous study with hypotensively resuscitated dogs 
that received enalaprilat was 2.3 k 0.2 ~lrninfrn~ (Wall et al., 2002), 0.7 ~ /min / rn~  greater 
than the average final cardiac index in the control dogs in this current protocol (average 
mean arterial pressures during the constant rate infusion period of 81 2 0 mm Hg). The 
greater blood flow with enalaprilat was achieved with a volume of lactated Ringer's 
solution that would otherwise likely have merely increased the mean arterial blood 
pressure without such a bonus effect on flow. Administration of 101 2 12 mLkg lactated 
Ringer's solution combined with enalaprilat resulted in mean arterial pressures of 40 - 45 
mm Hg with improved flows while the administration of 67 k 19 mL/kg lactated Ringer's 
solution without enalaprilat resulted in mean arterial pressures of 75 - 80 mm Hg with 
unimproved flows (Wall et al., 2002). 
Cardiovascular FZo w- Pressure Parameters During Resuscitation With Enalapriizt 
It has been suggested that, for assessing and guiding resuscitative interventions, using 
variables that combine blood flow information with blood pressure information may have 
advantages over using variables containing solely blood flow information (Chang et al., 
1998; Cbang et al., 2000). The flow-pressure parameters in this study (stroke work index, 
left vemtricular power output index, and arterial elastance index) were calculated using the 
thermodilution obtained systemic blood flow data since thermodilution is currently more 
commonly employed for monitoring systemic blood flow parameters than is ultrasound. 
Both stroke work index and left ventricular power output index ended higher in the 
animals that received enalaprilat while arterial elastance, a measure of afterload, ended 
lower with enalaprilat. This would suggest that part of the mechanism for the difference 
in cardiovascular performance is an enalaprilat-induced decrease in afterload (while 
preload was maintained with fluids). Another contributing factor is the increasing arterial 
elastance observed in the control group during resuscitation. This would suggest that 
increasing after load in the control animals led to their declining systemic and mesenteric 
flows. Observations from this current study of increasing afterload and decreasing 
mesenteric flows in the control animals is consistent with reports by others of progressive 
mesenteric A 1 arteriolar vasoconstriction and decreasing mesenteric A1 arteriolar flow 
during resuscitation with saline and shed blood (Fruchterman et al., 1998). 
Volume Of Lactated Ringer's Solution Required With Enalaprilat 
The greater fluid requirement, as titrated by the mean arterial pressure in the 
enalaprilat group, would not be unexpected. One of the reasons to administer enalaprilat 
is to decrease mesenteric resistance arteriole constriction; thereby increasing perfusion in 
vascular beds that would otherwise remain constricted. Enalaprilat-induced relaxation of I 
mesenteric resistance arterioles should not promote pooling of blood in mesenteric 
capacitance vessels. The pooling of blood in mesenteric capacitance vessels is a function 
of the contractile state of the mesenteric veins (Reilly et al., 2001), which are not as 
responsive to angiotensin I1 as are the rnesenteric arteries (Yamazaki et a!., 199 1). The 
fluid and blood pressure results of this current study suggest that it would not be prudent 
to decrease mesenteric, and therefore total peripheral resistance, without provision of 
fluids to perfuse the opened vascular beds. They would also tend to suggest that bolus 
administration of enalaprilat would not be wise. 
Volume Of Lactated Ringer S Solution In Controls 
A different resuscitation protocol would be to administer a predetermined volume of 
lactated Ringer's solution rather than titrating the administration to achieve a 
predetermined blood pressure. Since a pressure titrated protocol was chosen, one could 
ask whether the same systemic blood flows could have been achieved in the control dogs 
as the enalaprilat dogs by simply forcing more lactated Ringer's solution rather than 
titrating its administration according to each animal's blood pressure? Possibly, but how 
much lactated Ringer's solution and at what rate should it have been empirically given? 
While some Advanced Trauma Life Support courses recommend administration of 3 
times the shed blood ~ o l u m e  as crystalloid (ATLS7 1997)3 the actual shed blood volume 
is rarely bow in trauma patients and estimates of external blood loss by E M T ~  have 
been shown to be quite inaccurate (Patton et al.9 2001). Additionally, Healey et al 
(Healey et al., 200 1 ) have suggested a much higher ratio, on the order of 1 0 to 1 for 
cIystalloid to shed blood, should be used when dealing with vely severe hemonhage. In 
Iowa Methodist Medical Center's (Des Moines, IA) emergency department, fluid 
administration to trauma patients is governed by the clinician's assessment of the 
patient's condition and response to said fluids (also recommended in the ATLS course as 
more important than the "3 to 1 rule"), not by a magic ratio based on a guessed blood 
volume loss. Considering these factors and that two of the control dogs in our titrated 
resuscitation protocol achieved higher than target mean arterial blood pressures despite 
receiving the lowest volumes of lactated Ringer's solution, we are not comfortable with 
resuscitation protocols using one pre-set volume. 
Consideration of afterload issues would also suggest that simply forcing more lactated 
Ringer's solution into each dog, independent of the effect on mean arterial blood 
pressure, might not be equally advantageous to administering enalaprilat while titrating 
fluid administration. The contractile state of resistance arterioles has a considerably 
greater infh~ence on afterload and flow into a vascular bed than on venous return (Guyton 
et al.9 1 973)- The state of the venous capacitance vessels has a considerably greater 
influence on venous return than on afterload. Prevention of angioten~in II formation with 
enalaprilat predominantly affects the state of the rnesenteric resistance arterioles (Reilly et 
200 ; Yamazaki et al., 199 1). Elevated angiotensin 11 levels have been observed in 
ICU patients for a' least 6 days following admission ( ~ ~ l d t  et al., 1995a). If this were 
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combined with administration of more intravenous fluid than necessary for maintenance 
of mean arterial pressure, one could increase the volume in the capacitance vessels 
without specifically impacting the contractile state of the mesenteric resistance arterioles. 
While preload would likely be increased, afterload would not be specifically reduced. 
Comparison of Blood Flow Monitoring Techniques 
Thermodilution determined cardiac output and combined M-mode and pulsed 
Doppler ultrasonically determined descending thoracic aortic blood flow both show a 
generally declining systemic blood flow in the control animals following the initial 
resuscitation-induced increase. They also both show higher ending systemic blood flows 
in the enalaprilat group. The thennodilution cardiac output profiles, however, do not 
match the celiac arterial flow profiles as well as the descending thoracic aortic flow 
profiles match the celiac arterial flow profiles. The nonpassive nature of the commonly 
used intermittent thermodilution technique may account in part for this difference (at least 
three 10 mL cold boluses per measurement in this study in dogs with average stroke 
volumes of 6 to 22 mL depending on the time point in the protocol). An additional 
reason for closer agreement between the descending thoracic aortic and the celiac arterial 
flows would be that these two sites should have a greater shared variance with each other 
than would entire cardiac output and celiac arterial flow. This is because cardiovascular 
insults lead to differential regulation of mesenteric blood flow versus cardiac and cerebral 
blood ROW, which are not part of the descending thoracic aortic blood flow. This could 
be of benefit in monitoring trauma patients since direct monitoring of mesenteric 
perfusion is not generally done and since considerable evidence suggests that inadequate 
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mesenteric perhion can lead to both gastrointestinal (Reilly et al., 200 1) and systemic 
organ damage and dysfunction (Reilly et al., 200 1 ; Kioke et al., 1 994; Zallen et al., 1 999; 
Magnotti et al., 1998). 
As this study found, others have reported strong correlations between changes in 
descending thoracic aortic blood flows as measured ultrasonically with combined M- 
mode and pulsed Doppler technology and total cardiac output as measured by intermittent 
thermodilution, continuous thermodilution, and indirect calorimetry. The comparisons 
have been done in human patients as well as in experimental animals. Results from this 
study suggest that monitoring descending thoracic aortic blood flow rather than total 
cardiac output would be more useful for indicating of mesenteric flow. 
Esophageal And Gastrointestinal PiC02 During Resuscitation 
Esophageal, gastric, and duodenal PiC02 values increased during hemorrhage and 
decreased during resuscitation. Within the first 40 minutes of resuscitation, before the 
constant rate infusion of enalaprilat was started, the PiC02 values at all the monitored 
sites in both groups decreased to or below the pre-hemorrhage values. Despite the 
declining celiac arterial blood flow in the control dogs, the PiCOz values did not increase 
during resuscitation in the control dogs in the limited time course of this experiment. 
Whether differences in gastrointestinal PiCQ2 would develop between the enalaprilat and 
control groups given a longer resuscitation time frame is currently under investigation. 
Clinical Use Of Enalaprilat Post-Trauma 
The systemic blood flow increases when enalaprilat is administered as a constant rate 
infusion during resuscitation observed in this study agree with the clinical findings 
reported by others who have used enalaprilat for reasons other than the treatment of 
hypertension. An increase in cardiac index was observed by Kincaid et al. (Kincaid et al., 
1 998) in 1 0 trauma patients who received 0.625 mg enalaprilat in 1 00 ml of saline as an 
infusion over 4 hours. Improvements in cardiovascular status were observed in critically 
ill trauma and postoperative patients when enalaprilat was given at a rate of 0.5 mg/hr 
over 5 days as compared to controls (Boldt et al., 1995b). In a subsequent study 
involving forty septic surgical patients, enalaprilat administration at 0.25 mg/hr over 5 
days was not associated with an increase in cardiac index but was associated with a 
decrease in systemic vascular resistance index (Boldt et al., 1998). 
Angio tensin Converting Enzyme Inhibition Versus Receptor Blockade 
In addition to interrupting angiotensin 11-induced splanchnic vasoconstriction, 
enalaprilat may be beneficial during resuscitation in other ways. In the study involving 
septic surgical patients (Boldt et al., 1998), enalaprilat administration was associated with 
lower circulating levels of thrombomodulin and soluble leukocyte and endothelial cell 
adhesion molecules, a decrease in neutrophil count, a decrease in lactate, and an 
improvement in ventilation to perfusion ratio (PaO2/FiO2). Fewer of the enalaprilat 
treated patients developed severe sepsis or septic shock (Boldt et al., 1998). In an animal 
skin fold ischemia-reperfirsion model, enalaprilat prevented muscle cell death and 
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functional capillary density loss (Guba et al., 2000). In a tissue culture hypoxia- 
reoxygenation model, enalaprilat prevented up regulation of the endothelial cell adhesion 
molecules, ICAM-1 and VCAM-1, and neutrophil adherence to endothelial cells (Guba et 
al., 2000). Enalaprilat also blunted renal VCAM- 1 up-regultation in a ureteral 
obstruction model (Morissey et al., 1998), and attenuated hepatic ischemia-reperhion 
damage in a liver transplant model (Anthuber et al., 1997). Although the exact 
mechanisms resulting in these effects are still under study, it is clear that the effects noted 
in the ischemia-reperkion and hypoxia-reoygenation experiments and in the ureteral 
obstruction experiments were not related to the prevention of angiotensin I1 interaction 
with the angiotensin JI sub-type 1 receptor (Guba et al., 2000; Morrissey et al., 1998). 
Additionally, enalaprilat has been shown to decrease nuclear factor KB activation 
(Morrissey et al., 1997) and to decrease peripheral blood mononuclear cell production of 
TNFa and IL-1 by a posttranscriptional effect not present with all angiotensin 
converting enzyme inhibitors (Schindler et al., 1995). Additional work is needed to 
determine the role of enalaprilat as a modulator of the inflammatory consequences of 
hemorrhagic shock. 
CONCLUSION 
The data from this study demonstrates that enalaprilat has beneficial effects on 
systemic and mesenteric cardiovascular variables when administered during resuscitation 
in conjunction with intravenous lactated Ringer's solution. Further, these effects can be 
observed more accurately with continuous passive methods such as ultrasound than with 
intermittent active methods such as bolus-dependent therrnodilution techniques. 
Resuscitation in this model involved the administration of crystalloids only. The 
cardiovascular, metabolic, and immunomodulatory actions of enalaprilat should be 
investigated in a resuscitation model that includes the administration of banked packed 
red blood cells. 
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